653 related articles for article (PubMed ID: 21091684)
1. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.
Arenbergerova M; Gkalpakiotis S; Arenberger P
Int J Dermatol; 2010 Dec; 49(12):1445-9. PubMed ID: 21091684
[TBL] [Abstract][Full Text] [Related]
2. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
Harde V; Mrowietz U
J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
[TBL] [Abstract][Full Text] [Related]
3. Long-term successful adalimumab therapy in severe hidradenitis suppurativa.
Blanco R; Martínez-Taboada VM; Villa I; González-Vela MC; Fernández-Llaca H; Agudo M; González-López MA
Arch Dermatol; 2009 May; 145(5):580-4. PubMed ID: 19451504
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
Mekkes JR; Bos JD
Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504
[TBL] [Abstract][Full Text] [Related]
5. Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.
van Rappard DC; Leenarts MF; Meijerink-van 't Oost L; Mekkes JR
J Dermatolog Treat; 2012 Aug; 23(4):284-9. PubMed ID: 21756155
[TBL] [Abstract][Full Text] [Related]
6. Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy.
Lozeron P; Denier C; Lacroix C; Adams D
Arch Neurol; 2009 Apr; 66(4):490-7. PubMed ID: 19364934
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases.
Moschella SL
Int J Dermatol; 2007 Dec; 46(12):1287-91. PubMed ID: 18173525
[TBL] [Abstract][Full Text] [Related]
8. Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial.
Kimball AB; Kerdel F; Adams D; Mrowietz U; Gelfand JM; Gniadecki R; Prens EP; Schlessinger J; Zouboulis CC; van der Zee HH; Rosenfeld M; Mulani P; Gu Y; Paulson S; Okun M; Jemec GB
Ann Intern Med; 2012 Dec; 157(12):846-55. PubMed ID: 23247938
[TBL] [Abstract][Full Text] [Related]
9. [Hidradenitis suppurativa. Response to treatment with infliximab].
Pedraz J; Daudén E; Pérez-Gala S; Goiriz-Valdés R; Fernández-Peñas P; García-Diez A
Actas Dermosifiliogr; 2007 Jun; 98(5):325-31. PubMed ID: 17555675
[TBL] [Abstract][Full Text] [Related]
10. A prospective open-label clinical trial of efficacy of the every week administration of adalimumab in the treatment of hidradenitis suppurativa.
Sotiriou E; Goussi C; Lallas A; Chovarda E; Apalla Z; Lazaridou E; Ioannides D
J Drugs Dermatol; 2012 May; 11(5 Suppl):s15-20. PubMed ID: 22644772
[TBL] [Abstract][Full Text] [Related]
11. Summaries for patients. Adalimumab for the treatment of hidradenitis suppurativa.
Ann Intern Med; 2012 Dec; 157(12):I-50. PubMed ID: 23247950
[No Abstract] [Full Text] [Related]
12. Rotational therapy with TNF-alpha blockers for recalcitrant hidradenitis suppurativa.
Brunasso AM; Massone C
Eur J Dermatol; 2010; 20(5):644-6. PubMed ID: 20615818
[No Abstract] [Full Text] [Related]
13. Adalimumab in treatment-resistant hidradenitis suppurativa following recurrence after extensive affected area excision: a review of biologics therapy.
Samycia M; Brassard A
J Cutan Med Surg; 2013 Oct; 17 Suppl 1():S23-32. PubMed ID: 24144253
[TBL] [Abstract][Full Text] [Related]
14. Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab.
Alecsandru D; Padilla B; Izquierdo JA; Fernández-Cruz E; Sánchez-Ramón S
Arch Dermatol; 2010 Dec; 146(12):1343-5. PubMed ID: 21173317
[No Abstract] [Full Text] [Related]
15. Etanercept: effective in the management of hidradenitis suppurativa.
Cusack C; Buckley C
Br J Dermatol; 2006 Apr; 154(4):726-9. PubMed ID: 16536817
[TBL] [Abstract][Full Text] [Related]
16. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa.
Miller I; Lynggaard CD; Lophaven S; Zachariae C; Dufour DN; Jemec GB
Br J Dermatol; 2011 Aug; 165(2):391-8. PubMed ID: 21457202
[TBL] [Abstract][Full Text] [Related]
17. Interstitial keratitis secondary to severe hidradenitis suppurativa: a case report and literature review.
Alzaga Fernandez AG; Demirci H; Darnley-Fisch DA; Steen DW
Cornea; 2010 Oct; 29(10):1189-91. PubMed ID: 20628295
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
Reddick CL; Singh MN; Chalmers RJ
Dermatol Online J; 2010 Aug; 16(8):15. PubMed ID: 20804692
[TBL] [Abstract][Full Text] [Related]
19. Infliximab for the treatment of hidradenitis suppurativa.
Fernández-Vozmediano JM; Armario-Hita JC
Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers.
Delage M; Samimi M; Atlan M; Machet L; Lorette G; Maruani A
Acta Derm Venereol; 2011 Mar; 91(2):169-71. PubMed ID: 21384087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
